Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 4:01 pm Unchanged | 2024-01-31 | 13D | Outlook Therapeutics, Inc. OTLK | BioLexis Pte Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-29 4:01 pm Unchanged | 2023-11-29 | 13D | Outlook Therapeutics, Inc. OTLK | BioLexis Pte Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-07-07 9:51 pm Unchanged | 2022-07-07 | 13D | Outlook Therapeutics, Inc. OTLK | BioLexis Pte Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-04-22 4:30 pm Unchanged | 2022-04-22 | 13D | Outlook Therapeutics, Inc. OTLK | BioLexis Pte Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-01 4:58 pm Unchanged | 2022-02-01 | 13D | Outlook Therapeutics, Inc. OTLK | BioLexis Pte Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-12-01 5:27 pm Unchanged | 2021-12-01 | 13D | Outlook Therapeutics, Inc. OTLK | BioLexis Pte Ltd. | 0 0.000% | 0 (Unchanged) | Filing |